Business🇬🇧 +1· 4 hours agoGSK buys Nuvalent for $10.6 billion to deepen lung cancer pushWhat's new: GSK is paying $124 a share in cash, a 40% premium, and expects the deal to add revenue growth from 2027.#Gsk#NuvalentThe Business Times (Singapore), CNBC +1